Emily Leproust, ASHG 2020

preview_player
Показать описание
Speaker: Emily Leproust
ASHG 2020
  1. Twist Bioscience
Рекомендации по теме
Emily Leproust, ASHG 0:10:19

Emily Leproust, ASHG 2020

Emily Leproust of 0:00:18

Emily Leproust of Twist Bioscience offered this advice to anyone trying to solve a hard problem…

Dr. Emily LeProust, 0:01:01

Dr. Emily LeProust, Twist Bioscience, is BIO’s 2020 Rosalind Franklin Award winner

Writing the Future 0:12:42

Writing the Future of Drug Discovery and Development | Emily Leproust

Human Genetics and 0:03:39

Human Genetics and Genomics Advances Journal - 2019 ASHG

ASHG 2020 Virtual 0:06:00

ASHG 2020 Virtual Meeting Statistics

SINERGY Speaks to 0:11:02

SINERGY Speaks to Emily Leproust

Revealing the Unseen 0:15:45

Revealing the Unseen In Human Genome Sequencing

Leading the way 0:46:44

Leading the way in Sample Prep

Human Genetics and 0:29:29

Human Genetics and Engagement with Religious Publics: Ting Wu presentation at ASHG 2018

Implementation of Twist 0:16:27

Implementation of Twist Products in Clinical Genomics

ASHG TV 2021 0:18:16

ASHG TV 2021 Episode 3 - Wednesday 20 October

Twist AGBT2021 0:26:04

Twist AGBT2021

Using Twist technology 0:18:34

Using Twist technology to efficiently enrich 1.4M SNP targets for ancient DNA analysis | David Reich

ASHG 2019: Charles 0:17:38

ASHG 2019: Charles Rotimi & Sarah Tishkoff, Curt Stern Awardees

ASHG 2015: Leonid 0:16:00

ASHG 2015: Leonid Kruglyak, Stern Awardee

David Berman ASHG 0:16:34

David Berman ASHG 2019 Presentation

Helix - Alexandre 0:02:59

Helix - Alexandre Bolze, ASHG poster, 2020

Raising the Bar 1:36:12

Raising the Bar in NGS with Twist Bioscience

Accelerate GPCR Antibody 0:21:23

Accelerate GPCR Antibody Discovery with Synthetic DNA Technologies | Melina Mathur

No More Arrays: 0:12:06

No More Arrays: Genotyping by Sequencing Enables Economical and Improved Association Studies

In Silico Accelerated 0:21:20

In Silico Accelerated Antibody Characterization | Astrid Musnier

Genome-wide Screen of 0:23:54

Genome-wide Screen of SARS-CoV-2 Identifies Hyper-potent siRNAs for Nasal Administration | Y. Erlich

Data-Driven Development of 0:15:48

Data-Driven Development of a High-Throughput Target Enrichment System | Twist Bioscience | AGBT 2019

Комментарии
Автор

Thanks for sharing. I think I have understood 5% but it sounded like a plan. Bought a significant number of Twist Bioscience stocks. Also ordered some books. Will come back. Will understand more. Keep up the great work! Per aspera ad astra.

patrickznew